Apple: Steve Jobs' Liver Transplant

|

CNBC's Jim Goldman takes a look at how Apple's stock is reacting to news that the company's CEO had a liver transplant two months and expects to return to Apple at the end of June.

Comment
Show commentsHide Comments

Latest Markets Videos

Search Stock Quotes
Markets
Commodity Prices
Video Archives
Partner Videos